Articles From: Platform Specialty Products Corporation Announces Third Quarter 2014 Financial Results to NeoStem Announces Additions to Management


- Net sales of $197 million, up 4.4% organically - Record Adjusted EBITDA of $52.5 million and Adjusted EBITDA margin of 26.7% MIAMI, Nov.
Sign-up for Platform Specialty Products Corporation Announces Third Quarter 2014 Financial Results investment picks
Financial results to be released after the close of the market; Conference call to be conducted at 4:30 pm ET FIVE POINTS, Calif.
Sign-up for S&W Seed Company Sets First Quarter Fiscal 2015 Conference Call and Earnings Release for Tuesday, November 11, 2014 investment picks
New service delivered from a secure Unisys cloud to provide improved collaboration and investigative capabilities for UK Policing BLUE BELL, Pa.
Sign-up for UK Police Forces Select Unisys' HOLMES to Manage Criminal Investigations and Respond to Major Incidents investment picks
ServiceNow (NYSE:NOW), the enterprise IT cloud company, today announced ServiceNow Express, a new, easy-to-use, cloud-based IT service management (ITSM) solution.
Sign-up for ServiceNow Launches Express investment picks
SAN DIEGO , Nov.
Sign-up for Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference investment picks
PITTSBURGH , Nov.
Sign-up for PNC Executive to Speak at Citi Global Investor Conference investment picks
Splunk Inc. (NASDAQ:SPLK), provider of the leading platform for real-time Operational Intelligence, today announced that mail.de GmbH , a German provider of email services, is optimizing its email service and gaining real-time business insight by indexing, correlating and visualizing its machine data with Splunk® Enterprise.
Sign-up for mail.de Delivers on Customer Expectations with Splunk Enterprise investment picks
Louisiana-Pacific Corporation (LP) (NYSE: LPX) reported today results for the third quarter of 2014, which included the following: “LP’s financial results continue to be negatively affected by poor OSB pricing,” said Curt Stevens, CEO.
Sign-up for LP Reports Third Quarter 2014 Results investment picks
Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI), a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally driven diseases, today announced that updated, interim results from the company’s ongoing Phase 2 clinical trial, ARMOR2, of its lead drug candidate, galeterone, in patients with castration resistant prostate cancer (CRPC) will be presented at the 26 th EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held November 18-21 in Barcelona, Spain.
Sign-up for Tokai Pharmaceuticals Announces Interim Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer to be Presented at the EORTC-NCI-AACR Symposium investment picks
OM Asset Management plc (NYSE: OMAM) today reports its results for the third quarter and nine months ended September 30, 2014.
Sign-up for OMAM Reports Financial and Operating Results for the Third Quarter Ended September 30, 2014 investment picks
Nu Skin Enterprises' stock (NUS) tumbled 12% in premarket trade Wednesday, after the maker of skin care products provided a profit and sales outlook for the current quarter that was well below analyst projections.
Sign-up for Nu Skin's stock tumbles after profit, sales outlook disappoints investment picks
Jacobs Engineering Group Inc. (NYSE:JEC) announced today that it was awarded a contract by Martin Project Management, LLC.
Sign-up for Jacobs Awarded Construction Management Contract from Martin Project Management investment picks
Targacept, Inc. (NASDAQ: TRGT ), a clinical-stage biopharmaceutical company advancing NNR Therapeutics™, today reported its financial results for the third quarter and nine months ended September 30, 2014.
Sign-up for Targacept Reports Third Quarter 2014 Financial Results investment picks
PROVO, Utah , Nov.
Sign-up for Nu Skin Enterprises Declares Quarterly Dividend Of $0.345 investment picks
Vishay Precision Group, Inc. (NYSE: VPG), a leading producer of precision sensors and systems, based on its resistive foil technology, today announced financial results for its third quarter ended September 27, 2014.
Sign-up for VPG Reports Fiscal 2014 Third Quarter Results investment picks
INDIANAPOLIS , Nov.
Sign-up for Allison Transmission to Attend Baird Industrial Conference investment picks
Calgon Carbon Corporation (NYSE: CCC) reported results for the third quarter ended September 30, 2014.
Sign-up for Calgon Carbon Announces Third Quarter Results investment picks
-- REPORTS $0.49 DILUTED EARNINGS PER SHARE --
Sign-up for Sinclair Reports Third Quarter 2014 Financial Results investment picks
BALTIMORE , Nov.
Sign-up for Sinclair Declares $0.165 Per Share Quarterly Cash Dividend investment picks
PROVO, Utah , Nov.
Sign-up for Nu Skin Enterprises Reports Third-Quarter Results investment picks
Orbital Sciences Corporation (NYSE: ORB), one of the world’s leading space technology companies, today announced comprehensive plans to fulfill its contract commitments under NASA’s Commercial Resupply Services (CRS) program as well as to accelerate an upgrade of the Antares medium-class launcher’s main propulsion system.
Sign-up for Orbital Announces Go-Forward Plan for NASA’s Commercial Resupply Services Program and the Company’s Antares Launch Vehicle investment picks
- Third quarter contract revenue of $57.5 million, up 8% from 2013 - Lower Discovery and API revenue is offset by addition of OsoBio - OsoBio business interruption contributes to third quarter adjusted loss per share of $(0.02) - Full year 2014 contract revenue expected to be between $253 and $261 million, an increase of 22% at the midpoint - Full year adjusted diluted EPS range between $0.67 and $0.73, compared to $0.70 in 2013 - Company provides initial 2015 outlook - Company creates new Drug Product reporting segment to reflect addition of OsoBio ALBANY, N.Y. , Nov.
Sign-up for AMRI Announces Third Quarter 2014 Results investment picks
NEW YORK, Nov.
Sign-up for NeoStem Announces Additions to Management investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Platform Specialty Products Corporation Announces Third Quarter 2014 Financial Results to NeoStem Announces Additions to Management
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent